Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs.

Br J Cancer · 1998 · PMC2063102 · PMID 9716024

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP=0.001actually significant

5-HT enhanced the maximum anti-tumour response to the DMXAA/CI- 1010 combination; the effect of 5-HT was statistically significant in one of the two experiments, and was highly significant (P=0.001) if both experiments were pooled.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.